Literature DB >> 6461663

Factors involved in the control of proliferation of bovine corneal endothelial cells maintained in serum-free medium.

L Giguère, J Cheng, D Gospodarowicz.   

Abstract

Experimental conditions have been defined that allow bovine corneal endothelial (BCE) cells to grow in the complete absence of serum. Low density BCE cell cultures maintained on extracellular matrix (ECM)-coated dishes and plated in the total absence of serum proliferate actively when exposed to a synthetic medium supplemented with high density lipoprotein (HDL 500 micrograms protein/ml), transferrin (10 micrograms/ml), insulin (5 micrograms/ml), and fibroblast (FGF) or epidermal growth factor (EGF) added at concentrations of 100 or 50 ng/ml, respectively. Omission of any of these components results in a lower growth rate and/or final cell density of the cultures. BCE cell cultures plated on plastic dishes and exposed to the same synthetic medium grow very poorly. The longevity of BCE cultures maintained on plastic versus ECM and exposed to serum-free virus serum-containing medium has been studied. The use of ECM-coated dishes extended the life span of BCE cultures maintained in serum-supplemented medium to over 120 generations, as compared to less than 20 generations for cultures maintained on plastic. Likewise, BCE cells maintained on ECM and exposed to a synthetic medium supplemented with optimal concentrations of HDL, transferrin, insulin, and FGF underwent 85 generations, whereas control cultures maintained on plastic could not be passaged. The enhancing effect of ECM on BCE cell growth and culture longevity clearly illustrates the importance of the cell substrate in the control of proliferation of these cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6461663     DOI: 10.1002/jcp.1041100112

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  An optimized culture medium for human vascular endothelial cells from umbilical cord veins.

Authors:  P Friedl; D Tatje; R Czpla
Journal:  Cytotechnology       Date:  1989-08       Impact factor: 2.058

2.  High-density lipoproteins induce a rapid and transient release of Ca2+ in cultured fibroblasts.

Authors:  M I Pörn; K E Akerman; J P Slotte
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

3.  Optimization of culture conditions for human corneal endothelial cells.

Authors:  K Engelmann; P Friedl
Journal:  In Vitro Cell Dev Biol       Date:  1989-11

4.  Human dermal microvascular endothelial cells: an improved method for tissue culture and a description of some singular properties in culture.

Authors:  R M Marks; M Czerniecki; R Penny
Journal:  In Vitro Cell Dev Biol       Date:  1985-11

5.  Chicken egg yolk-supplemented medium and the serum-free growth of normal mammalian cells.

Authors:  D K Fujii; D Gospodarowicz
Journal:  In Vitro       Date:  1983-11

6.  A comparison of primary cultures of rat cerebral microvascular endothelial cells to rat aortic endothelial cells.

Authors:  E L Gordon; P E Danielsson; T S Nguyen; H R Winn
Journal:  In Vitro Cell Dev Biol       Date:  1991-04

7.  Fibroblast growth factor-2 protects endothelial cells from damage after corneal storage at 4 degrees C.

Authors:  Peter W Rieck; Ruth M von Stockhausen; Sylvia Metzner; Christian Hartmann; Yves Courtois
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-06       Impact factor: 3.117

8.  Optimization of culture conditions for porcine corneal endothelial cells.

Authors:  Stéphanie Proulx; Jean-Michel Bourget; Nicolas Gagnon; Sophie Martel; Alexandre Deschambeault; Patrick Carrier; Claude J Giasson; François A Auger; Isabelle Brunette; Lucie Germain
Journal:  Mol Vis       Date:  2007-04-03       Impact factor: 2.367

9.  Lysophosphatidic acid induces YAP-promoted proliferation of human corneal endothelial cells via PI3K and ROCK pathways.

Authors:  Yi-Jen Hsueh; Hung-Chi Chen; Sung-En Wu; Tze-Kai Wang; Jan-Kan Chen; David Hui-Kang Ma
Journal:  Mol Ther Methods Clin Dev       Date:  2015-04-29       Impact factor: 6.698

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.